Skip to main navigation Skip to search Skip to main content

Response to: "a somatization comorbidity phenotype impacts response to therapy in rheumatoid arthritis: Post hoc results from the certolizumab pegol phase 4 PREDICT trial"

  • Annelise Madison
  • , Barbara L. Andersen
  • , Ali Ajam

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Article number65
JournalArthritis Research and Therapy
Volume21
Issue number1
DOIs
StatePublished - Feb 20 2019

Cite this